Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. From late 2020 to the summer of 2024, Eli Lilly & Co.

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The ...

We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed. Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top ...

Eli Lilly (LLY) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American stock to currently cross the landmark threshold. The move came as ...

Fintel reports that on November 12, 2025, Citigroup maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy recommendation. Analyst Price Forecast Suggests 8.95% Downside As of November 9, 2025, ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Markets are coming back strong. All thanks to the news ...

Fintel reports that on November 10, 2025, Leerink Partners upgraded their outlook for Eli Lilly and (NYSE:LLY) from Market Perform to Outperform. Analyst Price Forecast Suggests 0.26% Upside As of ...

Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Rising Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) is seen as a strong heal‌thc‌a‍re stock that investors can ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Despite the company's run in recent years, it's not too late to buy. Even with headwinds it has encountered this year, the drugmaker is arguably one of the top stocks in its industry to buy right now.